An automated compounding system is a device that combines one or more drug solutions to a final container for patient administration. Automated compounding system helps avoid medication error that occurs due to a variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion while using similar labels. However, with the automated compounding systems, the accuracy and efficiency of dispensing compounded products have improved and reduced the exposure of healthcare professionals to toxic agents.
This report contains market size and forecasts of Automated Drug Compounding Systems in global, including the following market information:
Global Automated Drug Compounding Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Automated Drug Compounding Systems Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Automated Drug Compounding Systems companies in 2021 (%)
The global Automated Drug Compounding Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gravimetric Automated Compounding Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Automated Drug Compounding Systems include Baxter International Inc., Braun Melsungen AG, Comecer, ICU MEDICAL INC, Grifols, S.A., Omnicell, Equashield, ARxIUM and Weibond Technology and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Automated Drug Compounding Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Automated Drug Compounding Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automated Drug Compounding Systems Market Segment Percentages, by Type, 2021 (%)
Gravimetric Automated Compounding Systems
Volumetric Automated Compounding Systems
Global Automated Drug Compounding Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automated Drug Compounding Systems Market Segment Percentages, by Application, 2021 (%)
Hospitals
Chemotherapy Centers
Others
Global Automated Drug Compounding Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automated Drug Compounding Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Automated Drug Compounding Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Automated Drug Compounding Systems revenues share in global market, 2021 (%)
Key companies Automated Drug Compounding Systems sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Automated Drug Compounding Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter International Inc.
Braun Melsungen AG
Comecer
ICU MEDICAL INC
Grifols, S.A.
Omnicell
Equashield
ARxIUM
Weibond Technology
NewIcon